Mineralys Therapeutics, Inc.
Ownership
Ownership Structure
Who owns Mineralys Therapeutics, Inc. (MLYS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 75.3% of the shares are freely tradable; institutional investors hold 110.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Catalys Pacific LLC | 8.94 | 7,903,838 | +0.0 | 06/30/2026 |
| RA Capital Management, LLC | 8.70 | 7,692,750 | +0.0 | 06/30/2026 |
| BlackRock Inc | 6.66 | 5,887,038 | +31.4 | 06/30/2026 |
| Samsara BioCapital, LLC | 6.64 | 5,871,018 | +0.0 | 06/30/2026 |
| FMR Inc | 5.10 | 4,511,689 | -7.2 | 06/30/2026 |
| State Street Corp | 4.68 | 4,141,636 | +41.1 | 06/30/2026 |
| Deerfield Management Co | 4.48 | 3,958,000 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.12 | 2,756,770 | +12.3 | 06/30/2026 |
| LAURION CAPITAL MANAGEMENT LP | 2.83 | 2,506,152 | +12.3 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| American Funds SMALLCAP World A | 2.83 | 2,502,854 | +28.7 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Slingsby Brian Taylor | Director | 7,805,718 | 142,064,068 $ | Sep 22, 2026 | indirect |
| Congleton Jon | Chief Executive Officer | 528,621 | 9,620,902 $ | Sep 30, 2026 | direct |
| Ferguson James J. III | Chief Medical Officer | 102,400 | 1,863,680 $ | Aug 10, 2026 | direct |
| Rodman David Malcom | Chief Medical Officer | 51,384 | 935,189 $ | Aug 10, 2026 | direct |
| Warren Eric | Chief Commercial Officer | 38,400 | 698,880 $ | Sep 21, 2026 | direct |
| Coats Lonnel | Director | 12,400 | 225,680 $ | Oct 19, 2026 | direct |
| Peterson Kristine | Director | 12,400 | 225,680 $ | Oct 19, 2026 | direct |
| Karydas Daphne | Director | 6,200 | 112,840 $ | Sep 15, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Coats Lonnel | Director | Other | 12,400 | 0.00 | – |
| Oct 19, 2026 | Peterson Kristine | Director | Other | 12,400 | 0.00 | – |
| Sep 30, 2026 | Congleton Jon | Chief Executive Officer | Sell | 75,000 | 25.46 | 1,909,665 |
| Sep 22, 2026 | Slingsby Brian Taylor | Director | Sell | 104,320 | 28.81 | 3,005,303 |
| Sep 21, 2026 | Warren Eric | Chief Commercial Officer | Sell | 7,438 | 28.12 | 209,136 |
| Sep 21, 2026 | Warren Eric | Chief Commercial Officer | Other | 7,438 | 13.24 | 98,479 |
| Sep 15, 2026 | Karydas Daphne | Director | Sell | 3,000 | 28.58 | 85,740 |
| Sep 15, 2026 | Karydas Daphne | Director | Other | 3,000 | 12.02 | 36,060 |
| Aug 21, 2026 | Warren Eric | Chief Commercial Officer | Sell | 7,437 | 25.98 | 193,189 |
| Aug 21, 2026 | Warren Eric | Chief Commercial Officer | Other | 7,437 | 13.24 | 98,466 |
| Aug 10, 2026 | Ferguson James J. III | Chief Medical Officer | Other | 102,400 | 0.00 | – |
| Aug 10, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | 2,170 | 27.09 | 58,785 |
| Aug 10, 2026 | Rodman David Malcom | Chief Medical Officer | Other | 2,170 | 16.00 | 34,720 |
| Jul 21, 2026 | Warren Eric | Chief Commercial Officer | Sell | 7,438 | 26.87 | 199,885 |
| Jul 21, 2026 | Warren Eric | Chief Commercial Officer | Other | 7,438 | 13.24 | 98,479 |
| Jul 17, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | 416 | 26.53 | 11,036 |
| Jul 17, 2026 | Rodman David Malcom | Chief Medical Officer | Other | 416 | 15.44 | 6,423 |
| Jul 15, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | 6,349 | 26.61 | 168,955 |
| Jul 13, 2026 | Congleton Jon | Chief Executive Officer | Sell | 10,700 | 27.24 | 291,441 |
| Jul 13, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | 14,058 | 27.58 | 387,717 |
| Jul 13, 2026 | Rodman David Malcom | Chief Medical Officer | Other | 6,349 | 1.08 | 6,857 |
| Jul 13, 2026 | Rodman David Malcom | Chief Medical Officer | Other | 4,167 | 14.25 | 59,380 |
| Jul 13, 2026 | Rodman David Malcom | Chief Medical Officer | Other | 3,542 | 10.20 | 36,128 |
| Apr 17, 2026 | David Malcom Rodman | Insider | Sell | 416 | 31.33 | 13,033 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.